Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains

被引：11

作者：

Bantar, C ^{[1
]}

Di Chiara, M ^{[1
]}

Nicola, F ^{[1
]}

Relloso, S ^{[1
]}

Smayevsky, J ^{[1
]}

机构：

[1] Ctr Educ Med & Invest Clin Dr Norberto Quirno, Dept Microbiol, RA-1425 Buenos Aires, DF, Argentina

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2000年 / 37卷 / 01期

关键词：

D O I：

10.1016/S0732-8893(99)00156-X

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Fifteen unique isolates of carbapenem-resistant Pseudomonas aeruginosa were selected for time-kill studies to assess the bactericidal activity of cefepime (CFP) and ceftazidime (CZD) (at 4 and 16 mu g/mL), alone and associated with amikacin (AMK) (4 mu g/mL). CFP proved more active than CZD (p < 0.05, Student's t test). Bactericidal activity after 24-h incubation was only achieved by the combination of CFP (16 mu g/mL) plus AMK. The higher in vitro activity of cefepime over that of ceftazidime against imipenem-resistant P. aeruginosa strains highlights the differences of these drugs beyond Enterobacter spp. and Staphylococcus aureus. (C) 2000 Elsevier Science Inc. All rights reserved.

引用

收藏

页码：41 / 44

页数：4

相关论文

共 13 条

[1] SYNERGY CHARACTERIZATION FOR ENTEROCOCCUS-FAECALIS STRAINS DISPLAYING MODERATELY HIGH-LEVEL GENTAMICIN AND STREPTOMYCIN RESISTANCE [J].

BANTAR, CE ;

MICUCCI, M ;

CANIGIA, LF ;

SMAYEVSKY, J ;

BIANCHINI, HM .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1921-1923

[2] CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].

BARRADELL, LB ;

BRYSON, HM .

DRUGS, 1994, 47 (03) :471-505

[3] Pseudomonas aeruginosa:: a survey of resistance in 136 hospitals in Spain [J].

Bouza, E ;

Garcia-Garrote, F ;

Cercenado, E ;

Marin, M ;

Diaz, MS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :981-982

[4] DEVELOPMENT OF RESISTANCE IN PSEUDOMONAS-AERUGINOSA TO BROAD-SPECTRUM CEPHALOSPORINS VIA STEP-WISE MUTATIONS [J].

GRADELSKI, E ;

FUNGTOMC, J ;

HUCZKO, E ;

KESSLER, RE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :75-80

[5] PREDOMINANT PATHOGENS IN HOSPITAL INFECTIONS [J].

JARVIS, WR ;

MARTONE, WJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 :19-24

[6] ACTIVITY OF CEFEPIME AGAINST CEFTAZIDIME-RESISTANT GRAM-NEGATIVE BACILLI USING LOW AND HIGH INOCULA [J].

JOHNSON, CC ;

LIVORNESE, L ;

GOLD, MJ ;

PITSAKIS, PG ;

TAYLOR, S ;

LEVISON, ME .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (06) :765-773

[7] Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs:: A 1997 surveillance trial in 102 medical centers in the United States [J].

Jones, RN ;

Pfaller, MA ;

Doern, GV ;

Erwin, ME ;

Hollis, RJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (03) :215-228

[8] Carbapenem activities against Pseudomonas aeruginosa:: Respective contributions of OprD and efflux systems [J].

Köhler, T ;

Michea-Hamzehpour, M ;

Epp, SF ;

Pechere, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :424-427

[9] Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital [J].

Kuikka, A ;

Valtonen, VV .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (10) :701-708

[10] Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae [J].

Mimoz, O ;

Jacolot, A ;

Padoin, C ;

Tod, M ;

Samii, K ;

Petitjean, O .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (03) :367-372